Evaluation of the Charlson Comorbidity Index to Predict Early Mortality in Implantable Cardioverter Defibrillator Patients

By Bhavnani Sanjeev P.   Coleman Craig I.   Guertin Danette   Yarlagadda Ravi K.   Clyne Christopher A.   Kluger Jeffrey  

Annals of Noninvasive Electrocardiology, Vol. 18, Iss. 4, 2013-07 ,pp. : 379-388

Blackwell Publishing

Access to resources Recommend Favorite

Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?

By Al-Khatib Sana M.   Sanders Gillian D.   O’Brien Sean M.   Matlock Daniel   Zimmer Louise O.   Masoudi Frederick A.   Peterson Eric  

Annals of Noninvasive Electrocardiology, Vol. 16, Iss. 1, 2011-01 ,pp. : 77-84

Blackwell Publishing

Access to resources Recommend Favorite

Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death

By Spath M.A.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 727-738

Adis International

Access to resources Recommend Favorite

Examination of the Effect of Implantable Cardioverter-Defibrillators on Health-Related Quality of Life: Based on Results from the Multicenter Automatic Defibrillator Trial-II

By Noyes Katia  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 6, 2009-12 ,pp. : 393-400

Adis International

Access to resources Recommend Favorite

Implantable cardioverter defibrillators

By Harris Stuart   Dhinoja Mehul  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 397-400

Royal College Of Physicians

Access to resources Recommend Favorite